nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—SLC19A1—cleft lip	0.544	0.657	CbGaD
Methotrexate—TYMS—cleft lip	0.158	0.191	CbGaD
Methotrexate—MTHFR—cleft lip	0.126	0.152	CbGaD
Methotrexate—SLC19A1—tongue—cleft lip	0.00353	0.126	CbGeAlD
Methotrexate—FOLR1—mouth—cleft lip	0.00271	0.097	CbGeAlD
Methotrexate—Pralatrexate—SLC19A1—cleft lip	0.00269	0.341	CrCbGaD
Methotrexate—SLC19A1—mouth—cleft lip	0.00237	0.085	CbGeAlD
Methotrexate—ABCC11—embryo—cleft lip	0.00185	0.0663	CbGeAlD
Methotrexate—Tetrahydrofolic acid—MTR—cleft lip	0.00117	0.149	CrCbGaD
Methotrexate—ATIC—embryo—cleft lip	0.00109	0.0391	CbGeAlD
Methotrexate—GGH—telencephalon—cleft lip	0.00104	0.0374	CbGeAlD
Methotrexate—Raltitrexed—TYMS—cleft lip	0.00103	0.131	CrCbGaD
Methotrexate—FOLR1—head—cleft lip	0.000978	0.035	CbGeAlD
Methotrexate—ATIC—telencephalon—cleft lip	0.000887	0.0318	CbGeAlD
Methotrexate—SLC19A1—head—cleft lip	0.000857	0.0307	CbGeAlD
Methotrexate—Pralatrexate—TYMS—cleft lip	0.00078	0.0991	CrCbGaD
Methotrexate—Leucovorin—TYMS—cleft lip	0.00078	0.0991	CrCbGaD
Methotrexate—SLCO1C1—telencephalon—cleft lip	0.000737	0.0264	CbGeAlD
Methotrexate—DHFR—embryo—cleft lip	0.000732	0.0262	CbGeAlD
Methotrexate—SLC46A1—head—cleft lip	0.00066	0.0236	CbGeAlD
Methotrexate—MTHFR—telencephalon—cleft lip	0.000659	0.0236	CbGeAlD
Methotrexate—GGH—head—cleft lip	0.00065	0.0233	CbGeAlD
Methotrexate—Pemetrexed—TYMS—cleft lip	0.000624	0.0793	CrCbGaD
Methotrexate—TYMS—telencephalon—cleft lip	0.000602	0.0215	CbGeAlD
Methotrexate—DHFR—telencephalon—cleft lip	0.000596	0.0213	CbGeAlD
Methotrexate—PGD—telencephalon—cleft lip	0.000573	0.0205	CbGeAlD
Methotrexate—FPGS—head—cleft lip	0.000571	0.0204	CbGeAlD
Methotrexate—ATIC—head—cleft lip	0.000552	0.0198	CbGeAlD
Methotrexate—SLC16A1—telencephalon—cleft lip	0.000535	0.0191	CbGeAlD
Methotrexate—ABCC10—telencephalon—cleft lip	0.000491	0.0176	CbGeAlD
Methotrexate—SLCO1C1—head—cleft lip	0.000459	0.0164	CbGeAlD
Methotrexate—SLCO1A2—telencephalon—cleft lip	0.000423	0.0152	CbGeAlD
Methotrexate—MTHFR—head—cleft lip	0.000411	0.0147	CbGeAlD
Methotrexate—SLCO3A1—head—cleft lip	0.000404	0.0145	CbGeAlD
Methotrexate—Folic Acid—MTHFR—cleft lip	0.0004	0.0508	CrCbGaD
Methotrexate—Tetrahydrofolic acid—MTHFR—cleft lip	0.0004	0.0508	CrCbGaD
Methotrexate—TYMS—head—cleft lip	0.000375	0.0134	CbGeAlD
Methotrexate—DHFR—head—cleft lip	0.000371	0.0133	CbGeAlD
Methotrexate—PGD—head—cleft lip	0.000357	0.0128	CbGeAlD
Methotrexate—ABCC1—telencephalon—cleft lip	0.000347	0.0124	CbGeAlD
Methotrexate—SLC16A1—head—cleft lip	0.000333	0.0119	CbGeAlD
Methotrexate—ABCC3—head—cleft lip	0.000307	0.011	CbGeAlD
Methotrexate—ABCG2—telencephalon—cleft lip	0.000287	0.0103	CbGeAlD
Methotrexate—SLCO1A2—head—cleft lip	0.000264	0.00944	CbGeAlD
Methotrexate—ABCC4—head—cleft lip	0.000254	0.00908	CbGeAlD
Methotrexate—SLC22A8—head—cleft lip	0.000252	0.00901	CbGeAlD
Methotrexate—ABCB1—embryo—cleft lip	0.000174	0.00624	CbGeAlD
Methotrexate—ABCB1—telencephalon—cleft lip	0.000142	0.00508	CbGeAlD
Methotrexate—ABCB1—head—cleft lip	8.83e-05	0.00316	CbGeAlD
Methotrexate—TYMS—E2F transcription factor network—MYC—cleft lip	6.47e-05	0.000474	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SPRY2—cleft lip	6.45e-05	0.000472	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF7—cleft lip	6.45e-05	0.000472	CbGpPWpGaD
Methotrexate—AOX1—Disease—ABCA4—cleft lip	6.45e-05	0.000472	CbGpPWpGaD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—cleft lip	6.45e-05	0.000472	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TCN2—cleft lip	6.35e-05	0.000465	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	6.28e-05	0.00046	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF3—cleft lip	6.22e-05	0.000455	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ABCA4—cleft lip	6.2e-05	0.000454	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—MTR—cleft lip	6.18e-05	0.000452	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—MTR—cleft lip	6.18e-05	0.000452	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF9—cleft lip	6.06e-05	0.000444	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SLC19A1—cleft lip	6.04e-05	0.000442	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGF10—cleft lip	6.01e-05	0.00044	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ABCA4—cleft lip	6.01e-05	0.00044	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF8—cleft lip	5.95e-05	0.000436	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ABCA4—cleft lip	5.94e-05	0.000435	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF7—cleft lip	5.9e-05	0.000432	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC19A1—cleft lip	5.9e-05	0.000432	CbGpPWpGaD
Methotrexate—PGD—Disease—SPRY2—cleft lip	5.9e-05	0.000432	CbGpPWpGaD
Methotrexate—MTHFR—Disease—WNT3—cleft lip	5.88e-05	0.000431	CbGpPWpGaD
Methotrexate—DHFR—Disease—ABCA4—cleft lip	5.87e-05	0.000429	CbGpPWpGaD
Methotrexate—AOX1—Disease—WNT3—cleft lip	5.75e-05	0.000421	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MTR—cleft lip	5.75e-05	0.000421	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ABCA4—cleft lip	5.64e-05	0.000413	CbGpPWpGaD
Methotrexate—TYMS—Retinoblastoma (RB) in Cancer—MYC—cleft lip	5.62e-05	0.000412	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF8—cleft lip	5.44e-05	0.000398	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	5.39e-05	0.000395	CbGpPWpGaD
Methotrexate—DHFR—G1/S Transition—MYC—cleft lip	5.38e-05	0.000394	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC19A1—cleft lip	5.37e-05	0.000393	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—MTHFR—cleft lip	5.34e-05	0.000391	CbGpPWpGaD
Methotrexate—PGD—Disease—MTR—cleft lip	5.26e-05	0.000385	CbGpPWpGaD
Methotrexate—DHFR—Disease—WNT3—cleft lip	5.23e-05	0.000383	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ABCA4—cleft lip	5.22e-05	0.000382	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF10—cleft lip	5.11e-05	0.000374	CbGpPWpGaD
Methotrexate—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	5.08e-05	0.000372	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC19A1—cleft lip	5.06e-05	0.00037	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TCN2—cleft lip	5e-05	0.000366	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC19A1—cleft lip	4.94e-05	0.000362	CbGpPWpGaD
Methotrexate—AOX1—Disease—TCN2—cleft lip	4.89e-05	0.000358	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF3—cleft lip	4.84e-05	0.000355	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGFR2—cleft lip	4.83e-05	0.000353	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—MTR—cleft lip	4.81e-05	0.000352	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF9—cleft lip	4.72e-05	0.000346	CbGpPWpGaD
Methotrexate—TYMS—G1/S Transition—MYC—cleft lip	4.7e-05	0.000344	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MTHFR—cleft lip	4.65e-05	0.00034	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	4.59e-05	0.000336	CbGpPWpGaD
Methotrexate—DHFR—Mitotic G1-G1/S phases—MYC—cleft lip	4.54e-05	0.000332	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGFR1—cleft lip	4.5e-05	0.000329	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC19A1—cleft lip	4.49e-05	0.000329	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—TYMS—cleft lip	4.45e-05	0.000326	CbGpPWpGaD
Methotrexate—DHFR—Disease—TCN2—cleft lip	4.45e-05	0.000325	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF3—cleft lip	4.43e-05	0.000324	CbGpPWpGaD
Methotrexate—PGD—Metabolism—MTR—cleft lip	4.4e-05	0.000322	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF9—cleft lip	4.32e-05	0.000316	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGFR3—cleft lip	4.25e-05	0.000311	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	4.24e-05	0.000311	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TCN2—cleft lip	4.19e-05	0.000307	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—TYMS—cleft lip	4.12e-05	0.000301	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGFR2—cleft lip	4.1e-05	0.0003	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TCN2—cleft lip	4.09e-05	0.0003	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC19A1—cleft lip	4.09e-05	0.0003	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF10—cleft lip	3.98e-05	0.000292	CbGpPWpGaD
Methotrexate—TYMS—Mitotic G1-G1/S phases—MYC—cleft lip	3.96e-05	0.00029	CbGpPWpGaD
Methotrexate—FPGS—Disease—MTHFR—cleft lip	3.95e-05	0.000289	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC19A1—cleft lip	3.92e-05	0.000287	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SPRY2—cleft lip	3.89e-05	0.000285	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF7—cleft lip	3.89e-05	0.000285	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—MTHFR—cleft lip	3.89e-05	0.000285	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGFR1—cleft lip	3.83e-05	0.00028	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF7—cleft lip	3.8e-05	0.000278	CbGpPWpGaD
Methotrexate—AOX1—Disease—SPRY2—cleft lip	3.8e-05	0.000278	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—TYMS—cleft lip	3.79e-05	0.000277	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—TYMS—cleft lip	3.79e-05	0.000277	CbGpPWpGaD
Methotrexate—ABCC1—Disease—WNT9B—cleft lip	3.73e-05	0.000273	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TCN2—cleft lip	3.72e-05	0.000273	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TYMS—cleft lip	3.68e-05	0.00027	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF10—cleft lip	3.64e-05	0.000267	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGFR3—cleft lip	3.62e-05	0.000265	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC19A1—cleft lip	3.6e-05	0.000263	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF8—cleft lip	3.59e-05	0.000263	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF8—cleft lip	3.51e-05	0.000257	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB3—cleft lip	3.5e-05	0.000256	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MTR—cleft lip	3.47e-05	0.000254	CbGpPWpGaD
Methotrexate—DHFR—Disease—SPRY2—cleft lip	3.46e-05	0.000253	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF7—cleft lip	3.46e-05	0.000253	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TCN2—cleft lip	3.39e-05	0.000248	CbGpPWpGaD
Methotrexate—AOX1—Disease—MTR—cleft lip	3.39e-05	0.000248	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ABCA4—cleft lip	3.32e-05	0.000243	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—MTHFR—cleft lip	3.31e-05	0.000242	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—MTHFR—cleft lip	3.31e-05	0.000242	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGF2—cleft lip	3.29e-05	0.00024	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—TCN2—cleft lip	3.25e-05	0.000238	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC19A1—cleft lip	3.25e-05	0.000238	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NOS3—cleft lip	3.24e-05	0.000237	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	3.22e-05	0.000236	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGFR2—cleft lip	3.2e-05	0.000234	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF8—cleft lip	3.19e-05	0.000234	CbGpPWpGaD
Methotrexate—DHFR—Disease—MTR—cleft lip	3.08e-05	0.000226	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MTHFR—cleft lip	3.08e-05	0.000225	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC19A1—cleft lip	3.04e-05	0.000222	CbGpPWpGaD
Methotrexate—ABCC4—Ectoderm Differentiation—MYC—cleft lip	3.03e-05	0.000221	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	3e-05	0.000219	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TCN2—cleft lip	2.98e-05	0.000218	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGFR1—cleft lip	2.98e-05	0.000218	CbGpPWpGaD
Methotrexate—ABCC1—Disease—WNT3—cleft lip	2.96e-05	0.000217	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—TYMS—cleft lip	2.95e-05	0.000216	CbGpPWpGaD
Methotrexate—PGD—Disease—FGFR2—cleft lip	2.92e-05	0.000214	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF3—cleft lip	2.92e-05	0.000214	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—MTR—cleft lip	2.9e-05	0.000213	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF3—cleft lip	2.86e-05	0.000209	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF9—cleft lip	2.85e-05	0.000209	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MTR—cleft lip	2.84e-05	0.000208	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC19A1—cleft lip	2.83e-05	0.000207	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	2.82e-05	0.000207	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGFR3—cleft lip	2.82e-05	0.000206	CbGpPWpGaD
Methotrexate—PGD—Disease—MTHFR—cleft lip	2.81e-05	0.000206	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF2—cleft lip	2.79e-05	0.000204	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF9—cleft lip	2.78e-05	0.000204	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS3—cleft lip	2.76e-05	0.000202	CbGpPWpGaD
Methotrexate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	2.75e-05	0.000201	CbGpPWpGaD
Methotrexate—PGD—Disease—FGFR1—cleft lip	2.73e-05	0.000199	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—NOS3—cleft lip	2.71e-05	0.000199	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TYMS—cleft lip	2.7e-05	0.000197	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TCN2—cleft lip	2.69e-05	0.000197	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF3—cleft lip	2.6e-05	0.00019	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MTR—cleft lip	2.58e-05	0.000189	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—MTHFR—cleft lip	2.58e-05	0.000189	CbGpPWpGaD
Methotrexate—PGD—Disease—FGFR3—cleft lip	2.58e-05	0.000189	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC19A1—cleft lip	2.54e-05	0.000186	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF9—cleft lip	2.53e-05	0.000185	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TCN2—cleft lip	2.52e-05	0.000184	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC19A1—cleft lip	2.42e-05	0.000177	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF10—cleft lip	2.4e-05	0.000176	CbGpPWpGaD
Methotrexate—PGD—Metabolism—MTHFR—cleft lip	2.36e-05	0.000173	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTR—cleft lip	2.35e-05	0.000172	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF10—cleft lip	2.35e-05	0.000172	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TCN2—cleft lip	2.34e-05	0.000171	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NOS3—cleft lip	2.31e-05	0.000169	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NOS3—cleft lip	2.31e-05	0.000169	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	2.29e-05	0.000168	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTR—cleft lip	2.25e-05	0.000165	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC19A1—cleft lip	2.24e-05	0.000164	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF2—cleft lip	2.18e-05	0.000159	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS3—cleft lip	2.17e-05	0.000158	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MYC—cleft lip	2.15e-05	0.000157	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—cleft lip	2.15e-05	0.000157	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF10—cleft lip	2.14e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TCN2—cleft lip	2.11e-05	0.000154	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTR—cleft lip	2.07e-05	0.000151	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TCN2—cleft lip	2e-05	0.000147	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF2—cleft lip	1.99e-05	0.000146	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—cleft lip	1.96e-05	0.000144	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SPRY2—cleft lip	1.96e-05	0.000143	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF7—cleft lip	1.96e-05	0.000143	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	1.94e-05	0.000142	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGFR2—cleft lip	1.93e-05	0.000141	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGFR2—cleft lip	1.88e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTR—cleft lip	1.86e-05	0.000136	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TCN2—cleft lip	1.85e-05	0.000136	CbGpPWpGaD
Methotrexate—FPGS—Disease—MYC—cleft lip	1.83e-05	0.000134	CbGpPWpGaD
Methotrexate—AOX1—Disease—MTHFR—cleft lip	1.81e-05	0.000133	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF8—cleft lip	1.81e-05	0.000132	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGFR1—cleft lip	1.8e-05	0.000132	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—cleft lip	1.8e-05	0.000132	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TYMS—cleft lip	1.78e-05	0.00013	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGFR1—cleft lip	1.76e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTR—cleft lip	1.74e-05	0.000128	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TYMS—cleft lip	1.74e-05	0.000127	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGFR2—cleft lip	1.71e-05	0.000125	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGFR3—cleft lip	1.7e-05	0.000124	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—MYC—cleft lip	1.66e-05	0.000122	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGFR3—cleft lip	1.66e-05	0.000121	CbGpPWpGaD
Methotrexate—DHFR—Disease—MTHFR—cleft lip	1.65e-05	0.000121	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—cleft lip	1.64e-05	0.00012	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTR—cleft lip	1.62e-05	0.000119	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—cleft lip	1.61e-05	0.000118	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGFR1—cleft lip	1.6e-05	0.000117	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TYMS—cleft lip	1.58e-05	0.000116	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MTHFR—cleft lip	1.52e-05	0.000111	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGFR3—cleft lip	1.51e-05	0.000111	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—MYC—cleft lip	1.49e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF3—cleft lip	1.47e-05	0.000108	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTR—cleft lip	1.46e-05	0.000107	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—MYC—cleft lip	1.45e-05	0.000106	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TYMS—cleft lip	1.44e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF9—cleft lip	1.43e-05	0.000105	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MYC—cleft lip	1.42e-05	0.000104	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	1.42e-05	0.000104	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTR—cleft lip	1.39e-05	0.000102	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MTHFR—cleft lip	1.38e-05	0.000101	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC19A1—cleft lip	1.38e-05	0.000101	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF2—cleft lip	1.31e-05	9.61e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—MYC—cleft lip	1.3e-05	9.52e-05	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—MYC—cleft lip	1.3e-05	9.5e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—cleft lip	1.3e-05	9.48e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTR—cleft lip	1.29e-05	9.41e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF2—cleft lip	1.28e-05	9.39e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TYMS—cleft lip	1.27e-05	9.27e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—cleft lip	1.27e-05	9.26e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTHFR—cleft lip	1.26e-05	9.21e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC19A1—cleft lip	1.21e-05	8.86e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF10—cleft lip	1.21e-05	8.85e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—cleft lip	1.21e-05	8.83e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF2—cleft lip	1.17e-05	8.54e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—cleft lip	1.15e-05	8.42e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TCN2—cleft lip	1.14e-05	8.37e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TYMS—cleft lip	1.14e-05	8.36e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—cleft lip	1.11e-05	8.1e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—cleft lip	1.08e-05	7.94e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—cleft lip	1.06e-05	7.75e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TCN2—cleft lip	1e-05	7.34e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—cleft lip	9.98e-06	7.31e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TYMS—cleft lip	9.95e-06	7.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR2—cleft lip	9.7e-06	7.1e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—cleft lip	9.64e-06	7.05e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—cleft lip	9.34e-06	6.84e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	9.25e-06	6.77e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR1—cleft lip	9.04e-06	6.62e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TYMS—cleft lip	8.95e-06	6.55e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—cleft lip	8.78e-06	6.43e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—cleft lip	8.69e-06	6.36e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MYC—cleft lip	8.59e-06	6.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR3—cleft lip	8.55e-06	6.26e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TYMS—cleft lip	8.51e-06	6.23e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—cleft lip	8.41e-06	6.16e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MYC—cleft lip	8.39e-06	6.14e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTR—cleft lip	7.93e-06	5.8e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TYMS—cleft lip	7.88e-06	5.77e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—cleft lip	7.82e-06	5.72e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—cleft lip	7.72e-06	5.65e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MYC—cleft lip	7.63e-06	5.58e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—cleft lip	7.43e-06	5.44e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—cleft lip	7.31e-06	5.35e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—cleft lip	6.96e-06	5.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTR—cleft lip	6.95e-06	5.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—cleft lip	6.88e-06	5.04e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF2—cleft lip	6.6e-06	4.83e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—cleft lip	6.51e-06	4.77e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—cleft lip	6.06e-06	4.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—cleft lip	5.46e-06	3.99e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—cleft lip	5.18e-06	3.79e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TYMS—cleft lip	4.86e-06	3.56e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—cleft lip	4.8e-06	3.51e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MYC—cleft lip	4.32e-06	3.16e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TYMS—cleft lip	4.26e-06	3.12e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—cleft lip	4.25e-06	3.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—cleft lip	3.72e-06	2.72e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—cleft lip	2.96e-06	2.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—cleft lip	2.6e-06	1.9e-05	CbGpPWpGaD
